Marco Maccauro

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Integrating PSMA PET into urological practice: insights from a multidisciplinary Italian survey.

Integrating PSMA PET into urological practice: insights from a multidisciplinary Italian survey.

Journal: Minerva urology and nephrology

Published: June 19, 2026

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

Journal: Expert review of anticancer therapy

Published: May 06, 2026

Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision Oncology.

Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision Oncology.

Journal: Cancers

Published: March 30, 2026

Investigation of MicroRNAs as predictors of radioligand therapy response in gastroenteropancreatic neuroendocrine tumours.

Investigation of MicroRNAs as predictors of radioligand therapy response in gastroenteropancreatic neuroendocrine tumours.

Journal: Scientific reports

Published: August 26, 2025

Radioligand Therapies (RLTs) and Healthcare System Readiness: From the Experience in GEP-NET, a Retrospective Analysis on DRG and Mobility to Improve the Accessibility to the Future RLT in Italy.

Radioligand Therapies (RLTs) and Healthcare System Readiness: From the Experience in GEP-NET, a Retrospective Analysis on DRG and Mobility to Improve the Accessibility to the Future RLT in Italy.

Journal: Clinical drug investigation

Published: July 29, 2025

Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.

Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 06, 2025

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

Journal: ESMO open

Published: June 04, 2025

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 20, 2025

Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in Italy.

Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in Italy.

Journal: Cardiovascular and interventional radiology

Published: May 07, 2025

The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert Opinion.

The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert Opinion.

Journal: Advances in therapy

Published: April 24, 2025

Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries.

Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries.

Journal: Endocrine

Published: February 14, 2025

Radioembolization of hepatocellular carcinoma with 90Y glass microspheres: an earlier administration day unexpectedly improves tumour control probability.

Radioembolization of hepatocellular carcinoma with 90Y glass microspheres: an earlier administration day unexpectedly improves tumour control probability.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 10, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026